Centric Wealth Management Maia Biotechnology, Inc. Transaction History
Centric Wealth Management
- $383 Million
- Q3 2024
A detailed history of Centric Wealth Management transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Centric Wealth Management holds 68,219 shares of MAIA stock, worth $149,399. This represents 0.05% of its overall portfolio holdings.
Number of Shares
68,219
Previous 68,198
0.03%
Holding current value
$149,399
Previous $233,000
18.03%
% of portfolio
0.05%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding MAIA
# of Institutions
18Shares Held
1.47MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA566KShares$1.24 Million0.0% of portfolio
-
Halter Ferguson Financial Inc. Carmel, IN377KShares$825,0030.56% of portfolio
-
Geode Capital Management, LLC Boston, MA193KShares$421,7120.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$171,9600.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX45.7KShares$100,0830.0% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $23.9M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...